NCT02312232View on ClinicalTrials.gov

Pharmacokinetic Study in Healthy Males

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Parkinson's Disease
Interventions
DRUG

levodopa, carbidopa, ODM-104

Trial Locations (1)

20520

CRST, Turku

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT02312232 - Pharmacokinetic Study in Healthy Males | Biotech Hunter | Biotech Hunter